Kobophenol A 白藜蘆醇四聚體
Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19
Recently, Many purchases of Kobophenol A products by customers has increased abnormally, and it is reported in the literature that Kobophenol A can be used as a good lead compound against COVID-19. The current scientific research is undoubtedly epidemic COVID-19. Now our company exclusively provides Kobophenol A products, which have a good anti-COVID-19 through the research of scientific staff.
At present, we are able to supply Kobophenol A at a high level, and invest a lot of money and time to expand the production of Kobophenol A to meet sales contracts signed. we hope that our research and development results will bring good help to the scientific community.
Journal of Physical Chemistry Letters: (IF 2021: 6.795)
Copyright: American Chemical Society
Source: https://pubs.acs.org/doi/10.1021/acs.jpclett.0c03119
| CAS# | 124027-58-3 |
| Purity | >=98% |
| M.W. | 925.0 |